Which Companies Are Making Covid Vaccines
Have you considered which companies are making covid vaccines? According to Singapore's Straits Times, Indonesia began officially organizing nationwide vaccination with the new inactivated crown vaccine purchased from China and developed by Kexing. "We are very optimistic." At a press conference organized by Indonesian vaccine production company BioFarma, Indonesian Ministry of Health spokesperson Siti Nadia Tamizi, made no secret of his confidence in the vaccine from China's Kexing.
Scientists study which companies are making covid vaccines. He pointed out that from the data, the Chinese covid vaccine had previously "worked quite well" in a number of countries, including Brazil and Turkey, and the phase III clinical trials organized in Indonesia had proved this point. India's Ministry of Health plans to officially start vaccination in the second to third week of January.
The first shipment of the new crown vaccine, developed by China's Kexing Bioproducts, arrived in Indonesia in December last year. According to a statement by Indonesian President Joko, Indonesia has reached an agreement with Kexing to ship tens of millions of doses of the vaccine's raw material directly to Indonesia in December last year and January this year, in addition to ordering the finished covid inactivated vaccine, which will be produced directly by local Indonesian company BioFarma. Indonesian Finance Minister Muyenyi said that currently, the Indonesian government plans to provide free vaccination to 120 million people within two years.
The Indonesian Ministry of Health said that the government is ready to officially launch a mass vaccination program nationwide starting January 13. President Joko himself will be the first person to receive the vaccine. Indonesia has high hopes for the Chinese vaccine. And the results of the Phase III clinical trial of the Kexing vaccine have confirmed their optimistic expectations. Some experiments have demonstrated which companies are making covid vaccines.
Just last December, after tests, the Turkish side confirmed that the effectiveness of the Chinese Kexing vaccine was above 90 percent, and the governor of the Brazilian state of São Paulo, Jonio Doria, publicly stated at a press conference on January 7 that local trials of the vaccine had proven that the effectiveness of the Chinese Kexing vaccine was close to 100 percent for patients with moderate to severe disease.
The Wall Street Journal noted that more and more developing countries are looking to China for vaccines. The inactivated vaccine developed by China Kexing is far less expensive to make and transport than the Pfizer vaccine, making it easier to achieve large-scale transport, storage and distribution in areas that are not very developed.
Academician Zhong Nanshan pointed out that to really control the epidemic, residents should be vaccinated in addition to strict prevention, and both sides should be done simultaneously to solve the problem. He said the world is now waiting for the results of the vaccine in China.So, which companies are making covid vaccines?
The data released by the scientific research and research group of the joint prevention and control mechanism of the Chinese State Council shows that the current annual production capacity of Chinese vaccines is close to 5 billion doses, and the production is expected to exceed 3 billion doses this year, which will be gradually realized in the second half of the year. With the increase in China's vaccine production capacity, China is doing its best to provide more safe and effective vaccines to the world, especially to developing countries, and to promote the equitable distribution and use of vaccines worldwide.
A growing body of clinical data has demonstrated that Chinese vaccines have unparalleled advantages in terms of safety, efficacy, and the feasibility of large-scale scale-up. Currently, China has participated in the New Crown Pneumonia Vaccine Implementation Program and has been in use in several countries, including the United Arab Emirates and Bahrain.
Looking for chemical products? Let suppliers reach out to you!
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Indian Variant Vaccine Efficacy is only 10%, and it was abandoned by South Africa
-
Compensation Methods For Adverse Reactions To Vaccines In The Post-Epidemic Period
-
The Johnson & Johnson Vaccine Is Only 72% Effective, Is It An Inferior Vaccine?
-
Research On The Distribution Of The Incubation Period Of COVID-19
-
How Many Covid Vaccines Are Made Per Second?
-
Protein Based Vaccines Examples : The Second Generation Of The COVID-19 Vaccine Is Coming
-
Does Vaccine Protect Against Omicron? Zhang Wenhong : Vaccination Booster Is Still An Effective Tool To Deal With Omicron
-
Are Covid Vaccines Patented ?
-
Several Domestic New Crown Mrna Companies Turn To Developing Broad-Spectrum Vaccines, Exploring Against Different Mutant Strains
-
Unable to get the new crown vaccine for medical reasons What can I do to protect myself?
Recommend Reading
-
Anastrozole Side Effects: What You Need to Know
-
Why You Should Never Mix Bleach and Vinegar
-
Benzoylecgonine: Detection and Testing Methods
-
Viprostol Usage & Precautions: What You Need to Know
-
How to Get Rid of Sulfur Burps Fast: Natural Remedies That Work
-
Business Society’s Market Outlook for Isooctanol on September 3, 2026: Strong Rebound with a Bullish Bias
-
Business Society’s Market Outlook for Epichlorohydrin on September 2, 2026: Price Trend Is Expected to Be Volatile
-
Business Society’s Market Outlook for Acrylic Acid on September 3, 2026: Trending with Volatility
-
Business Society’s Market Outlook for Acetic Acid on September 3, 2026: Clearly Upward Trend
-
Business Society’s Ethanol Market Outlook on September 3, 2026: Clearly Upward Trend